Chitomed

Chitomed is a biotechnology company based in the Netherlands, focusing on advanced medical, pharmaceutical, and cosmetic solutions utilizing chitosan and its derivatives. The company operates from the Medace facility in Maastricht, where it conducts research, development, and manufacturing within a dynamic life sciences environment. Chitomed aims to be a leading manufacturer of biodegradable polymer-based bone substitute implants and to develop effective prevention methods for conditions like osteoporosis and osteoarthritis. The company offers a range of innovative products, including a chitosan hydrogel designed as a bone substitute for orthopedic and dental surgeries. This hydrogel is injectable and solidifies at body temperature, allowing for precise filling of bone defects. Chitomed also employs 3D printing technology for customized medical implants and develops medical devices and dermocosmetic products that incorporate chitosan. Their high-purity, thermosensitive hydrogels serve various applications, including wound dressings and drug carriers. Chitomed collaborates closely with medical professionals to ensure the safety and efficacy of its products.

• Employees 1